Primary Objectives
The objectives are to describe the characteristics and outcomes of participants who attend at least one session of MCGP:
1. Describe demographic, clinical characteristics, reasons for referral, and IMC utilization data for participants who attend MCGP.
2. Examine anxiety, depression, quality of life, meaning in life, and fear of cancer recurrence before and after participation in MCGP.
3. Describe satisfaction and qualitative feedback from group participants, including perceived effectiveness and outcomes, experiences participating in the group virtually, and reactions to specific elements of the therapy modified for cancer survivors, length of group (90 minutes), and the nature of a closed group within the IMC.
Secondary Objectives
4. Examine whether demographic, clinical, or symptoms-based (pre) measures are associated with number of MCGP sessions attended.
5. Examine whether number of sessions attended is associated with change in outcome measures.